Target intelligence / Profile preview

Cellular and paracrine targets

Molecular classification
Other
01

Overview

The term 'Cellular and paracrine targets' refers to a broad conceptual category rather than a specific molecular entity like a receptor or enzyme. It encompasses the various cell types and the local signaling environment—specifically paracrine signaling, where cells communicate with nearby neighbors via secreted factors—that a therapy aims to influence (Gnecchi et al., 2016, PubMed). This terminology is most common in the fields of regenerative medicine and cell-based therapies, such as those involving mesenchymal stem cells (MSCs), where the therapeutic effect is often mediated by a complex 'secretome' of cytokines and growth factors rather than a single drug-receptor interaction (Caplan & Correa, 2011, PubMed). Cellular targets in this context might include resident stem cells or immune cells, while paracrine targets include the signaling molecules and their respective receptors within the tissue microenvironment. Because this phrase describes a multi-faceted physiological process involving numerous proteins and cell types, it is considered too broad to be a discrete therapeutic target. It lacks a single canonical structure, specific interacting drugs, or a unified mechanism of action, making it a descriptive classification for complex biological interactions (PMC4131274). Consequently, it is often used in research to describe the holistic impact of a treatment on a tissue system rather than a targeted molecular intervention.

Other names
Cellular targetsParacrine signaling targetsLocal signaling targets
02

Mechanism of action

Not applicable as this is a broad category of targets rather than a single molecule.

03

Biological functions

Cell-cell signalingParacrine signalingTissue regenerationSecretome-mediated signaling
04

Disease associations

OtherTissue injuryDegenerative diseases
05

Safety considerations

Off-target effects due to broad signaling impactComplexity in characterizing multi-component secretomesDifficulty in standardizing therapeutic dosage for multi-target paracrine effects

Beyond the preview

Go deeper on Cellular and paracrine targets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular and paracrine targets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call